Literature DB >> 26140910

Update and Review: Maternal Serum Screening.

K E Ormond1.   

Abstract

Maternal serum levels of alpha fetoprotein (AFP), human chorionic gonadotropin (hCG), and unconjugated estriol (uE3) can be used to screen pregnancies for neural tube defects, Down syndrome, Trisomy 18, and pregnancy complications. This article summarizes the most recent information regarding maternal serum screening, including genetic counseling issues.

Entities:  

Year:  1997        PMID： 26140910     DOI： 10.1023/A:1025648926821

Source DB:  PubMed          Journal:  J Genet Couns        ISSN： 1059-7700            Impact factor:   2.537


  108 in total

1.  Second-trimester maternal serum alpha-fetoprotein levels in pregnancies associated with gastroschisis and omphalocele.

Authors:  G E Palomaki; L E Hill; G J Knight; J E Haddow; M Carpenter
Journal:  Obstet Gynecol       Date:  1988-06       Impact factor: 7.661

2.  Elevated maternal serum alpha-fetoprotein levels: what is the risk of fetal aneuploidy?

Authors:  S Thiagarajah; C B Stroud; F Vavelidis; J A Schnorr; P T Schnatterly; J E Ferguson
Journal:  Am J Obstet Gynecol       Date:  1995-08       Impact factor: 8.661

3.  Unexplained elevation in maternal serum alpha-fetoprotein and subsequent fetal loss.

Authors:  J E Maher; R O Davis; R L Goldenberg; L R Boots; M B DuBard
Journal:  Obstet Gynecol       Date:  1994-01       Impact factor: 7.661

4.  Impact of abnormal second-trimester maternal serum single, double, and triple screening on patient choices about prenatal diagnosis.

Authors:  D L Lowry; S A Campbell; E L Krivchenia; E Dvorin; D Duquette; M I Evans
Journal:  Fetal Diagn Ther       Date:  1995 Sep-Oct       Impact factor: 2.587

5.  Prenatal diagnosis of neural tube defects. VIII. The importance of serum alpha-fetoprotein screening in diabetic pregnant women.

Authors:  A Milunsky; E Alpert; J L Kitzmiller; M D Younger; R K Neff
Journal:  Am J Obstet Gynecol       Date:  1982-04-15       Impact factor: 8.661

6.  Clinical interpretation of maternal serum alpha-fetoprotein concentrations.

Authors:  M J Adams; G C Windham; L M James; F Greenberg; J A Clayton-Hopkins; C B Reimer; G P Oakley
Journal:  Am J Obstet Gynecol       Date:  1984-02-01       Impact factor: 8.661

7.  Low maternal serum unconjugated estriol during prenatal screening as an indication of placental steroid sulfatase deficiency and X-linked ichthyosis.

Authors:  D F Keren; J A Canick; M Z Johnson; J D Schaldenbrand; R V Haning; R Hackett
Journal:  Am J Clin Pathol       Date:  1995-04       Impact factor: 2.493

8.  Elevated second-trimester maternal serum hCG alone or in combination with elevated alpha-fetoprotein.

Authors:  P A Benn; D Horne; S Briganti; J F Rodis; J M Clive
Journal:  Obstet Gynecol       Date:  1996-02       Impact factor: 7.661

9.  Cesarean section before the onset of labor and subsequent motor function in infants with meningomyelocele diagnosed antenatally.

Authors:  D A Luthy; T Wardinsky; D B Shurtleff; K A Hollenbach; D E Hickok; D A Nyberg; T J Benedetti
Journal:  N Engl J Med       Date:  1991-03-07       Impact factor: 91.245

10.  Are routine alpha-fetoprotein and acetylcholinesterase determinations still necessary at second-trimester amniocentesis? Impact of high-resolution ultrasonography.

Authors:  W Sepulveda; A Donaldson; R D Johnson; G Davies; N M Fisk
Journal:  Obstet Gynecol       Date:  1995-01       Impact factor: 7.661
View more
  1 in total

1.  To Use or Not to Use: The Prenatal Genetic Technology/Worry Conundrum.

Authors:  R Kenen; A C Smith; C Watkins; C Zuber-Pittore
Journal:  J Genet Couns       Date:  2000-06       Impact factor: 2.537
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.